Patents Assigned to BEIJING FORELANDPHARMA CO. LTD.
  • Patent number: 10047084
    Abstract: This application relates to imidazolone compounds, pharmaceutically acceptable salts, solvents, polymorphs or prodrugs thereof, and further relates to pharmaceutical combinations comprising the foregoing substances and uses for preventing and treating protein kinase related diseases such as cancer, metabolic diseases, and cardiovascular diseases.
    Type: Grant
    Filed: November 14, 2014
    Date of Patent: August 14, 2018
    Assignee: BEIJING FORELANDPHARMA CO. LTD.
    Inventors: Xingmin Zhang, Qi Ji, Lei Wang, Congmin Gao, Ensi Wang, Zhenjian Du, Longlong Gong, Bo Chen
  • Publication number: 20160304510
    Abstract: This application relates to imidazolone compounds, pharmaceutically acceptable salts, solvents, polymorphs or prodrugs thereof, and further relates to pharmaceutical combinations comprising the foregoing substances and uses for preventing and treating protein kinase related diseases such as cancer, metabolic diseases, and cardiovascular diseases.
    Type: Application
    Filed: November 14, 2014
    Publication date: October 20, 2016
    Applicant: BEIJING FORELANDPHARMA CO. LTD.
    Inventors: Xingmin ZHANG, Qi JI, Lei WANG, Congmin GAO, Ensi WANG, Zhenjian DU, Longlong GONG, Bo CHEN